How patients and others react to prostate cancer diagnosis and treatment

According to a media release issued earlier today by ZERO — The End of Prostate Cancer in conjunction with Ferring Pharmaceuticals Inc., “Prostate cancer impacts sex lives more than any other aspect of patients’ lives.” … READ MORE …

The choice of active surveillance: patient and partner perceptions

Two recent papers in the journal Psycho-oncology offer us interesting insights into patients’ (and their partners’) current perceptions about the role of active surveillance in the management of low-risk, localized prostate cancer. … READ MORE …

What’s being presented at ASCO this year: III

Another interesting presentation being made at the ASCO annual meeting this year will be the first report on a series of nearly 400 patients who did not conform to what would normally be considered a series of sound criteria for low risk disease. These patients all elected, as individuals, to go on actiuve surveillance despite their higher than average risk for progression. … READ MORE …

“Best care” doesn’t equate to better outcomes! That’s not good!

A poster by Schroeck et al. — to be presented on May 20 at the upcoming annual meeting of the American Urological Association (AUA) — presents the latest set of data suggesting that “best care” does not lead to appropriate outcomes quality for men receiving standard forms of treatment for localized prostate cancer. … READ MORE …

Use of expectant management more than doubles since 2004

According to a presentation at the Genitourinary Cancers Symposium, there has been a significant, recent increase in the numbers of men with low-risk prostate cancer who get care in the USA through some form of expectant management (active surveillance, watchful waiting, etc.). … READ MORE …

Criteria for active surveillance are gradually improving

Being diagnosed with low-risk prostate cancer is a good reason to consider management under active surveillance (as opposed to immediate, early intervention) … but active surveillance won’t be right for every low-risk patient! … READ MORE …

Medium-term follow-up of > 450 men on active surveillance in UK study

A large, single-institution study of active surveillance in England, just reported European Urology,  has again demonstrated the potential value of active surveillance in the management of low-risk prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,144 other followers